RapidAI
PrivateLast Round
Early Stage
VC
Feb 17, 2026
Total Funding Raised
$105.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RapidAI operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series C round in July 2023.
RapidAI is a healthcare technology company that provides an AI-powered clinical decision support platform for the analysis of medical imaging to assist clinicians in the diagnosis and management of stroke and other vascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RapidAI Comparables
Compare RapidAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viz.ai | 93% | |
| Aidoc | 87% | |
| Brainomix | 83% |
For institutional investors. Book with your work email.
RapidAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Feb 17, 2026 | ||||
| Series C | Jul 27, 2023 | ||||
| Series B | Sep 17, 2020 | ||||
| Series A | Jan 10, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RapidAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Listwin Ventures | Series B, Series C |
| Vista Credit Partners | Series C |
| Lennertz & Co. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
Added 257.co, a design agency, as a customer.
- Jun 4, 2026
Added OpenEyes, a healthcare technology startup, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withNov 2, 2026
RapidAI plans to integrate NEUROPHET, Inc.'s Neurophet AQUA AD Plus into its Rapid Enterprise Platform and begin full-scale distribution in the United States, initially focusing on memory disorders centers that prescribe Leqembi and Kisunla, with further integration planned for Neurophet AQUA and Neurophet SCALE PET.
- attends_eventSep 16, 2026
RapidAI's Rapid Aortic is named a finalist in the Artificial Intelligence Design category of Fast Company's 2026 Innovation by Design Awards.
- recognized_asSep 16, 2026
Fast Company names RapidAI's Rapid Aortic a finalist in the Artificial Intelligence Design category of its 2026 Innovation by Design Awards.
- launchesSep 12, 2026
RapidAI launches EdgeIQ on Sep 12th '26' to match imaging studies to the right AI models during acquisition, route them by urgency, and push them to clinicians as part of the Rapid Enterprise Platform.
- partners_withSep 2, 2026
RapidAI and Gravity MedTech collaborate in India to advance connected stroke care by combining clinical AI and care coordination with interventional thrombectomy technologies, announced on Sep 3rd '26.
For institutional investors. Book with your work email.
RapidAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RapidAI's valuation, stock price, and market status.
Is RapidAI a public or private company?
RapidAI is a private company.
What is the current stock price of RapidAI?
RapidAI is a private company, so its shares have no public market price. Caplight tracks RapidAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RapidAI worth (valuation)?
Valuation information for RapidAI is not publicly available.
Can I buy RapidAI stock?
RapidAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RapidAI's last funding round?
RapidAI's most recent funding round was Early Stage VC on February 17, 2026.
Who are the main investors in RapidAI?
Key investors in RapidAI include Vista Credit Partners, Lennertz & Co..
Will RapidAI IPO soon?
No public IPO plans have been announced for RapidAI.
How can I track RapidAI secondary market activity?
Caplight tracks bids, offers, and trades in RapidAI's shares on secondary markets.